Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin.
about
Cefixime in urinary tract infections with special reference to pediatrics: overview.Single-dose oral cefixime versus amoxicillin plus probenecid for the treatment of uncomplicated gonorrhea in men.In vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232, and its prodrug esters.beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance.In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.Penetration of cefixime into fibrin clots and in vivo efficacy against Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus.Biliary excretion of cefixime: assessment in patients provided with T-tube drainageCefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.Cefixime disk susceptibility test criteria.The future of new oral antibiotics including the quinolones.Cefixime penetration in human renal parenchyma.In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against Neisseria gonorrhoeaeIn vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin.Influence of an antacid containing aluminum and magnesium on the pharmacokinetics of cefixime.BMY 28100, a new oral cephalosporin.Comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074)In vitro susceptibility of Haemophilus influenzae to cefixime.In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolitesIn vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).Phase I study of cefixime, a new oral cephalosporin.Clinical pharmacology of cefixime in unweaned calves.Comparative in vitro activity of the new oral cephalosporin cefixime.Respiratory superinfections after the use of third-generation cephem antibiotics.Comparative activity of cefixime and cefaclor in an in vitro model simulating human pharmacokinetics.
P2860
Q34237047-0DAA0D91-F199-48C5-9764-8C9EA5A77E39Q34631585-E6ECB8C8-4B22-4878-A749-DEC859516E4BQ35326715-35130CEC-4921-451C-819B-D3ED512D701AQ35343778-B4BFF22D-C190-46A3-BA7F-08691041EE48Q35352378-DC8A3779-981F-4F67-AD69-C30C2F01B652Q35653815-A7DAF17F-E936-45F9-AE51-5F0E0D7A2FB6Q35817082-0EDD1DA0-8DAC-4F1F-A4E0-22B2BB8E9EF6Q36723783-6D95337D-3433-4859-BCE2-5A277F45A9F7Q36752721-ADBB868E-6E78-4394-8757-02DF290AD916Q37211155-DCECB475-47D8-4664-8C9E-50A3B962EFEDQ39625405-11D8DC11-B3DB-4E2D-84BA-718CA44CBC52Q39779827-7FFB35F0-857F-4703-855D-762CEDAA1D6AQ39815452-FA86EA00-CDBA-4134-AC0B-FFB9F021E0E9Q39818163-772613CB-6F39-43DE-A111-4E1FD59BD277Q39820140-92F1655F-75F4-4AC1-A8A9-9353A64A5F0DQ39820336-CA6E5679-CF70-43B5-9701-FDB647504763Q39827644-C4130551-69A0-4910-AF62-DE9388E3E21AQ39827907-28AD306D-A592-4CC3-A4E9-C9029E0535C3Q39829121-76F7CD59-88E6-4EFB-9020-5F29D2840767Q39851267-1ED322B8-E62D-45DC-B88B-F446E12D2B8EQ39851545-E359EA11-FCCD-41CF-93F7-EFD6C8597216Q44783271-8C5A0A6D-39A0-4CBB-837A-3D1C85614CF7Q50144376-A31BB271-F1F5-43A0-B679-11EC061ED37FQ50197814-00BDE49F-05CE-4EA7-9CCB-FB790C44CEB1Q50579504-047721CD-01A8-42CF-A5C0-70B607C4A47BQ54353067-9998F655-4126-4979-B7E5-896288C6FBA0
P2860
Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Comparative in vitro activity ...... w orally active cephalosporin.
@en
type
label
Comparative in vitro activity ...... w orally active cephalosporin.
@en
prefLabel
Comparative in vitro activity ...... w orally active cephalosporin.
@en
P2093
P2860
P356
P1476
Comparative in vitro activity ...... w orally active cephalosporin.
@en
P2093
P2860
P304
P356
10.1128/AAC.26.2.174
P407
P577
1984-08-01T00:00:00Z